Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Matthew McGirt

Neurological Surgery Charlotte, NC Medical Doctor

NPI 1073665550 CMS profile 507801

225 Baldwin Ave, Charlotte, NC 28204

Open in the dashboard

General payments

$692,636

252 records reported · program years 2019–2025

Research payments

$30,000

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Matthew McGirt of Charlotte, NC is reported in the CMS Open Payments database as having received $692,636 across 252 general payments and $30,000 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $27,464 10
2024 General $74,556 35
2023 General $35,888 36
2023 Research $15,000 1
2022 General $92,191 63
2022 Research $15,000 1
2021 General $130,903 17
2020 General $74,139 27
2019 General $257,495 64

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew McGirt
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Matthew McGirt were reported at $27,464. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Matthew McGirt Neurological Surgery median Middle half National median
2019 $257,495 $582 $138–$3,006 $163
2020 $74,139 $294 $76–$2,174 $114
2021 $130,903 $387 $105–$2,432 $132
2022 $92,191 $542 $139–$2,989 $149
2023 $35,888 $534 $145–$2,697 $160
2024 $74,556 $574 $155–$3,046 $164
2025 $27,464 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. MiRus, LLC $463,459 81 payments
  2. Stryker Corporation $106,236 90 payments
  3. Globus Medical, Inc. $88,282 55 payments
  4. VB Spine LLC $21,042 3 payments
  5. SpineSmith Holdings, LLC $6,775 2 payments
  6. Bioventus LLC $6,089 5 payments
  7. Carlsmed, Inc. $214 1 payment
  8. Medtronic USA, Inc. $133 1 payment
  9. Kuros Biosciences USA, Inc $118 3 payments
  10. Medtronic, Inc. $53 2 payments
  11. Other $235 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $426,194 63 payments
  2. Royalty or License $210,000 1 payment
  3. Travel and Lodging $26,157 91 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $24,650 6 payments
  5. Food and Beverage $5,635 91 payments
Products named General payments · program years 2019–2025
  1. EUROPA Pedicle Screw System $463,459 81 payments
  2. CYGNUS Anterior Cervical Plate $450,792 76 payments
  3. RIGEL 3DR Cervical Interbody $43,582 24 payments
  4. IO Expandable Lumbar Interbody $43,582 24 payments
  5. MiRus 3DR Lumbar Interbody System $43,582 24 payments
  6. TRITANIUM $28,311 25 payments
  7. MAKO $26,659 16 payments
  8. EVEREST SPINAL SYSTEM $23,315 14 payments
  9. Oscillating High Speed Drill $20,900 5 payments
  10. CANYON RETRACTOR SYSTEMS $17,625 1 payment
  11. Other $154,465 143 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Bioventus LLC $30,000 2 payments

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

233

Median for Neurosurgery: 83

Drug cost

$2,017

Median for Neurosurgery: $872

Branded share of claims

0%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 63 $711
Methocarbamol Generic 46 $524
Methylprednisolone Generic 48 $320
Cyclobenzaprine Hcl Generic 24 $267
Tizanidine Hcl Generic 39 $182
Meloxicam Generic 13 $14

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 69 billing codes

Paid by Medicare

$284,880

Medicare's payments for the services billed

Medicare patients

244

Average age 73

Services billed

911

117 women, 127 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 36%
Ischemic heart disease 34%
Depression 32%
Chronic kidney disease 28%
Osteoporosis 20%
Heart failure 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

254 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record